Nano-Emulsion Based Gel for Topical Delivery of an Anti-Inflammatory Drug: In vitro and in vivo Evaluation
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s407475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Dalia A Gaber und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraidah, 52571, Saudi Arabia. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Analgesics. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Arthritic disorder is a common disease in elderly patients and the most common cause of joint dysfunction. This study aims to design Piroxicam-loaded nanoemulsion (PXM-NE) formulations to enhance the analgesic and anti-inflammatory activity of the drug for topical use.
Methods
The nanoemulsion preparations were designed based on a high-pressure homogenization technique and were characterized for particle size (PS), poly dispersity index (Pi), zeta potential (ZP), drug content, and the selected formula was investigated for its topical analgesic activity and pharmacokinetic parameters.
Results
The characterizations showed that the PS was 310.20±19.84 nm, Pi was 0.15±0.02, and ZP was -15.74±1.6 mV for the selected formula. A morphology study showed that the PXM-NE droplets were spherical with a uniform size distribution. The in vitro release study showed a biphasic release pattern with a rapid release within the first 2 hours followed by a sustained release pattern. The analgesic activity for optimal formula was 1.66 times higher than the commercial gel with a double duration of analgesic activity. The Cmax was 45.73±9.95 and 28.48±6.44 ng/mL for the gel form of the selected formula and the commercial gel respectively. The relevant bioavailability of the selected formula was 2.41 higher than the commercial gel.
Conclusion
The results showed good physicochemical properties, higher bioavailability, and a longer analgesic effect of PXM from nanoemulsion gel, as compared to the commercial product.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraidah, 52571, Saudi Arabia.
- College of Pharmacy, Qassim University, Buraidah, 52571, Saudi Arabia.
- Department of Organic Chemistry, National Research Center, Giza, Egypt.
Zitieren
APA
Gaber, D. A., Alsubaiyel, A. M., Alabdulrahim, A. K., Alharbi, H. Z., Aldubaikhy, R. M., Alharbi, R. S., Albishr, W. K., & Mohamed, H. A. (2023). Nano-Emulsion Based Gel for Topical Delivery of an Anti-Inflammatory Drug: In vitro and in vivo Evaluation. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s407475
Vancouver
Gaber DA, Alsubaiyel AM, Alabdulrahim AK, Alharbi HZ, Aldubaikhy RM, Alharbi RS, et al. Nano-Emulsion Based Gel for Topical Delivery of an Anti-Inflammatory Drug: In vitro and in vivo Evaluation. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s407475
BibTeX
@article{Gaber2023,
author = {Gaber, Dalia A and Alsubaiyel, Amal M and Alabdulrahim, Alanoud K and Alharbi, Hanan Z and Aldubaikhy, Rama M and Alharbi, Rawan S and Albishr, Wades K and Mohamed, Heba A},
title = {Nano-Emulsion Based Gel for Topical Delivery of an Anti-Inflammatory Drug: In vitro and in vivo Evaluation},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s407475}
}
EUVIMED